Seattle biotech company is the first to receive approval to test B cell gene therapy in humans

Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the company announced Thursday. Immusoft says it’s the first to get permission to use engineered immune system cells called B cells in a human study. The U.S. Food and Drug Administration (FDA) approved Immusoft’s Investigational New […]

Read More »